Quick Answer
iBio, Inc. reported Stockholders Equity of $14.88 million for the year ending 2025.
- iBio, Inc. showed a decrease of -30.2% in Stockholders Equity from 2024 to 2025.
- This data is from iBio, Inc.'s annual report (Form 10-K), filed with the SEC on September 5, 2025.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2011: $886.1 thousand | Q4 2011: $305.5 thousand | Q1 2012: $6.85 million | Q3 2012: $4.57 million | Q4 2012: $3.72 million | Q1 2013: $2.30 million | Q3 2013: $5.68 million | Q4 2013: $7.95 million | Q1 2014: $7.00 million | Q3 2014: $5.44 million | Q1 2015: $10.19 million | Q3 2015: $9.81 million | Q4 2015: $7.88 million | Q1 2016: $8.27 million | Q3 2016: $7.14 million | Q4 2016: $4.15 million | Q1 2017: $12.95 million | Q3 2017: $6.29 million | Q4 2017: $7.81 million | Q1 2018: $4.15 million | Q3 2018: $13.03 million | Q4 2018: $11.08 million | Q1 2019: $6.91 million | Q3 2019: -$1.93 million | Q4 2019: -$511.0 thousand | Q1 2020: $3.97 million | Q3 2020: $80.05 million | Q4 2020: $107.34 million | Q1 2021: $104.85 million | Q3 2021: $100.54 million | Q4 2021: $90.60 million | Q1 2022: $79.38 million | Q3 2022: $48.37 million | Q4 2022: $18.82 million | Q1 2023: $17.39 million | Q3 2023: $13.21 million | Q4 2023: $9.20 million | Q1 2024: $24.86 million | Q3 2024: $17.75 million | Q4 2024: $13.90 million | Q1 2025: $11.38 million | Q2 2025: $14.88 million | Q3 2025: $56.04 million | Q4 2025: $56.56 million.
- Over the full 15 years of available data (2011 to 2025), iBio, Inc.'s Stockholders Equity has grown by 7,491.8%.
- Historical annual values: Fiscal year 2025: $14.88 million | Fiscal year 2024: $21.32 million | Fiscal year 2023: $15.38 million | Fiscal year 2022: $63.49 million | Fiscal year 2021: $108.59 million | Fiscal year 2020: $56.62 million | Fiscal year 2019: $2.46 million | Fiscal year 2018: $16.17 million | Fiscal year 2017: $8.91 million | Fiscal year 2016: $9.94 million | Fiscal year 2015: $11.23 million | Fiscal year 2014: $6.10 million | Fiscal year 2013: $5.07 million | Fiscal year 2012: $6.17 million | Fiscal year 2011: $196.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: